NCI to Support Epigenetics Studies of Cancer

genomeweb
360dx

NCI to Support Epigenetics Studies of Cancer

Nov 30, 2009

NEW YORK (GenomeWeb News) – The National Cancer Institute has issued a new grant program that will support population-based studies aimed at creating understanding of how epigenetics may be used to study the development of cancer.

To read the full story....

...and receive Daily News bulletins.

Already have an account?
Login Now.

Breaking News

FDA Approves Expanded Use of Agilent Assay as Keytruda CDx for Urothelial Cancer
Gene Editing Firm Recombinetics Closes $34M Series A Round
PerkinElmer Adds DNA Quality Assessment Analyzer to Agena Nucleic Acid Detection System
Akonni Biosystems Scores $3M NIH Grant for POC Dx Platform, Drug-Resistant TB Assay
Caprion Acquires Primity Bio
MBio Diagnostics Raises Additional $6M in Series B Funding Round

The Scan

All So Similar

23andMe's Anne Wojcicki ponders DNA and what it means to be human in a New York Times essay.

A Very Long Time Ago Indeed

A new estimate places the last universal common ancestor to life on Earth as living 3.9 billion years ago, Inverse reports.

This Week in PNAS

In PNAS this week: retinitis pigmentosa gene therapy, role of microbiome in growth stunting, and more.

Genetic Condition to Drug Inspiration

Bloomberg reports that researchers and drug companies are modeling anti-obesity treatments after the rare genetic condition essential fructosuria.

Main menu